Improving viral genome sequencing in veterinary labs
COVID-19: Viral whole genome sequencing protocols for routine application at veterinary diagnostic laboratories
This study is all about making it easier and cheaper for veterinary labs to use advanced DNA testing to find and understand different viruses, so they can help keep our pets healthy.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Minnesota NIH-funded |
| Lab location | 1 site (Minneapolis, United States) |
| Project ID | NIH-10828998 on NIH RePORTER |
What this research studies
This research focuses on enhancing the use of next generation sequencing (NGS) technologies in veterinary diagnostic laboratories to identify and characterize viral strains. It aims to provide practical recommendations for selecting the right sequencing platforms and protocols that are cost-effective and efficient for routine diagnostics. By addressing the challenges of high costs and the complexity of NGS, the project seeks to make viral sequencing more accessible for veterinary labs. The University of Minnesota's veterinary diagnostic lab will leverage its resources and expertise to develop these protocols.
Who could benefit from this research
Good fit: Ideal candidates for this research include veterinary diagnostic laboratories looking to implement or improve their viral sequencing capabilities.
Not a fit: Patients who are not involved in veterinary diagnostics or do not have access to veterinary care may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate and timely viral diagnostics in veterinary medicine, improving animal health outcomes.
How similar studies have performed: While there have been numerous studies on NGS technologies, this research aims to provide practical applications specifically for veterinary diagnostics, making it a novel approach.
Where this research is happening
Minneapolis, United States
- University of Minnesota — Minneapolis, United States (Active)
Researchers
- Principal investigator: Rovira, Albert — University of Minnesota
- Study coordinator: Rovira, Albert
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.